Secondary analysis of the ASPREE trial (n = 13,541) screening 1848 polygenic scores: in the highest quintile of a platelet-count score, aspirin vs placebo was associated with less dementia (HR 0.28) but more major bleeding (HR 2.13). Hypothesis-generating.
Secondary analysisn = 13,541
Fransquet et al. Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia